Literature DB >> 3761864

Requiem for gouty nephropathy.

L H Beck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3761864     DOI： 10.1038/ki.1986.179

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  16 in total

Review 1.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Use and abuse of allopurinol.

Authors:  J S Cameron; H A Simmonds
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

Review 3.  Uric acid and chronic kidney disease: which is chasing which?

Authors:  Richard J Johnson; Takahiko Nakagawa; Diana Jalal; Laura Gabriela Sánchez-Lozada; Duk-Hee Kang; Eberhard Ritz
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

4.  Treatment of Asymptomatic Hyperuricemia: When do you have a good reason to provide therapy?

Authors:  R M Richardson
Journal:  Can Fam Physician       Date:  1991-02       Impact factor: 3.275

Review 5.  Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment.

Authors:  Y T Chen
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

6.  Ischemia heart disease and greater waist circumference are risk factors of renal function deterioration in male gout patients.

Authors:  Ben Yu-Jih Su; Han-Ming Lai; Chung-Jen Chen; Ying-Chou Chen; Chun-Kai Chiu; Ko-Ming Lin; Shan-Fu Yu; Tien-Tsai Cheng
Journal:  Clin Rheumatol       Date:  2007-11-20       Impact factor: 2.980

7.  Serum uric acid levels and long-term outcomes in chronic kidney disease.

Authors:  Tokiko Miyaoka; Toshio Mochizuki; Takashi Takei; Ken Tsuchiya; Kosaku Nitta
Journal:  Heart Vessels       Date:  2013-08-09       Impact factor: 2.037

8.  Posing the question again: does chronic uric acid nephropathy exist?

Authors:  Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

Review 9.  The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.

Authors:  Yuka Sato; Daniel I Feig; Austin G Stack; Duk-Hee Kang; Miguel A Lanaspa; A Ahsan Ejaz; L Gabriela Sánchez-Lozada; Masanari Kuwabara; Claudio Borghi; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2019-07-11       Impact factor: 28.314

Review 10.  Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.

Authors:  Abutaleb Ahsan Ejaz; Takahiko Nakagawa; Mehmet Kanbay; Masanari Kuwabara; Ada Kumar; Fernando E Garcia Arroyo; Carlos Roncal-Jimenez; Fumihiko Sasai; Duk-Hee Kang; Thomas Jensen; Ana Andres Hernando; Bernardo Rodriguez-Iturbe; Gabriela Garcia; Dean R Tolan; Laura G Sanchez-Lozada; Miguel A Lanaspa; Richard J Johnson
Journal:  Semin Nephrol       Date:  2020-11       Impact factor: 5.299
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.